Article Abstract

Management of recurrent epithelial ovarian cancer

Authors: Víctor Manuel Vargas-Hernández, Mario Adan Moreno-Eutimio, Gustavo Acosta-Altamirano, Víctor Manuel Vargas-Aguilar


Epithelial ovarian cancer is the fifth most common cancer in women. It is usually diagnosed at an advanced stage and is the leading cause of death from gynecologic cancers in women. The overall survival rate at five years is 50% and its treatment is still poor. We need new treatments for patients with recurrent ovarian cancer who are incurable with current management. We review the effectiveness of new biological agents and morbidity and mortality of cytoreductive surgery. Since the hyperthermic increases the effectiveness of chemotherapy and the chance of survival, hyperthermic intraperitoneal chemotherapy has been proven to be a promising option, however it still requires further study to be the standard treatment.